Literature DB >> 27856533

Neurogenic fever in a patient with a chordoid glioma.

Rafael García Carretero1, Marta Romero Brugera2, Oscar Vazquez-Gomez3, Noelia Rebollo-Aparicio2.   

Abstract

Chordoid gliomas are rare tumours. Despite being considered low-grade neoplasms, recent reviews have reported generally poor prognosis due to complications involving severe hypothalamic symptoms. We report a patient aged 30 years with chordoid glioma. What makes this case report interesting is the presence of neurogenic fever, which was already present before the final diagnosis of the brain tumour and also several months after the surgical removal. Since the patient underwent a subtotal resection of the tumour, it remains unclear whether the fever was due to hypothalamic dysfunction or remnants of the tumour. We also performed temperature logging with a continuous-monitoring recording device. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2016        PMID: 27856533      PMCID: PMC5129222          DOI: 10.1136/bcr-2016-218205

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

Review 1.  Prognostic factors for recurrence and complications in the surgical management of primary chordoid gliomas: A systematic review of literature.

Authors:  Leonel Ampie; Winward Choy; Jonathan B Lamano; Kartik Kesavabhotla; Qinwen Mao; Andrew T Parsa; Orin Bloch
Journal:  Clin Neurol Neurosurg       Date:  2015-08-19       Impact factor: 1.876

2.  Third ventricular chordoid glioma: a distinct clinicopathologic entity.

Authors:  D J Brat; B W Scheithauer; S M Staugaitis; S C Cortez; K Brecher; P C Burger
Journal:  J Neuropathol Exp Neurol       Date:  1998-03       Impact factor: 3.685

3.  Chordoid gliomas of the third ventricle share TTF-1 expression with organum vasculosum of the lamina terminalis.

Authors:  Franck Bielle; Chiara Villa; Marine Giry; Anne-Marie Bergemer-Fouquet; Marc Polivka; Alexandre Vasiljevic; Marie-Hélène Aubriot-Lorton; Michèle Bernier; Emmanuèle Lechapt-Zalcman; Gabriel Viennet; Véronique Sazdovitch; Charles Duyckaerts; Marc Sanson; Dominique Figarella-Branger; Karima Mokhtari
Journal:  Am J Surg Pathol       Date:  2015-07       Impact factor: 6.394

4.  Neurogenic fever after traumatic brain injury: an epidemiological study.

Authors:  H J Thompson; J Pinto-Martin; M R Bullock
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-05       Impact factor: 10.154

5.  Holter monitoring of central and peripheral temperature: possible uses and feasibility study in outpatient settings.

Authors:  Manuel Varela; David Cuesta; Juan Antonio Madrid; Juan Churruca; Pau Miro; Raul Ruiz; Carlos Martinez
Journal:  J Clin Monit Comput       Date:  2009-07-16       Impact factor: 2.502

6.  Therapeutic approach to chordoid glioma of the third ventricle.

Authors:  Tatsuya Kobayashi; Takahiko Tsugawa; Chisa Hashizume; Norio Arita; Hisashi Hatano; Kenichiro Iwami; Yoichi Nakazato; Yoshimasa Mori
Journal:  Neurol Med Chir (Tokyo)       Date:  2013       Impact factor: 1.742

Review 7.  [Chordoid glioma of the III ventricle. Case report and revision of the literature].

Authors:  M Ortega-Martínez; J M Cabezudo; L M Bernal-García; I Fernández-Portales; L Gómez-Perals; R Gómez de Tejada; J J Pimentel
Journal:  Neurocirugia (Astur)       Date:  2007-04       Impact factor: 0.553

Review 8.  Human brain temperature: regulation, measurement and relationship with cerebral trauma: part 1.

Authors:  Charmaine Childs
Journal:  Br J Neurosurg       Date:  2008-08       Impact factor: 1.596

9.  Description of a portable wireless device for high-frequency body temperature acquisition and analysis.

Authors:  David Cuesta-Frau; Manuel Varela; Mateo Aboy; Pau Miró-Martínez
Journal:  Sensors (Basel)       Date:  2009-09-28       Impact factor: 3.576

10.  Chordoid glioma: a rare radiologically, histologically, and clinically mystifying lesion.

Authors:  Daniele Bongetta; Andrea Risso; Patrizia Morbini; Giorgio Butti; Paolo Gaetani
Journal:  World J Surg Oncol       Date:  2015-05-28       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.